ライフサイエンスコーパス: nanoemulsion

1 equivalent between free drug and drug loaded nanoemulsion.

2 BHT in increasing the stability of lycopene nanoemulsion.

3 ormulated with a novel oil-in-water cationic nanoemulsion.

4 de micelles or corresponding perfluorocarbon nanoemulsions.

5 res by preparing fluorescent perfluorocarbon nanoemulsions.

6 to examine the possible hepatic toxicity of nanoemulsions.

7 relatively high ( approximately 66%) in LCT nanoemulsions.

8 he Ostwald ripening commonly associated with nanoemulsions.

9 of these AOT stabilized regular and reverse nanoemulsions.

10 rent physico-chemical characteristics of O/W nanoemulsions.

11 Trolox increased the oxidative stability of nanoemulsions (100 MPa) and acted synergistically with B

12 Carotenoid nanoemulsions (100 MPa) were partially (66%) digested an

13 Oil-in-water antimicrobial nanoemulsions (10wt%) were formed by titrating a mixture

14 cellular uptake of lutein by Caco-2 cells in nanoemulsions (872.9+/-88.3pmol/mgprotein) than conventi

15 ine antigen, ID93, formulated in a synthetic nanoemulsion adjuvant, GLA-SE, administered in combinati

16 olecular imaging signatures of the presented nanoemulsions allow for future in vivo monitoring of the

17 The pH-sensing nanoemulsions allow the study of the fate of the PFC tra

18 The antimicrobial activity of the nanoemulsions also depended on the nature of the ripenin

19 Both, the cationic nanoemulsion and the CREKA-peptide-modified nanoemulsion

20 was observed for antimicrobial activities of nanoemulsions and LAE in tryptic soy broth.

21 Nanoemulsions and microemulsions are environments where

22 functional nanomaterials to form functional nanoemulsions and nanoparticles in one step.

23 elles, liposomes, solid lipid nanoparticles, nanoemulsions and nanosuspensions.

24 system were studied for polymeric micelles, nanoemulsions, and nanoemulsion-encapsulated drug.

25 mulated these fluorinated ligands as aqueous nanoemulsions, and then metallated them with various tra

26 However, under the same condition anise oil nanoemulsion (AO75) reduced E. coli O157:H7 and L. monoc

27 The nanoemulsion appeared to amplify the antibacterial activ

28 These nanoemulsions are formulated to readily enter cells upon

29 Oil-in-water nanoemulsions are particularly suitable for encapsulatio

30 stability and rheology of 5wt% oil-in-water nanoemulsions as a function of lentil protein isolate co

31 ngly support the future use of the presented nanoemulsions as anti-COX-2 theranostic nanomedicine wit

32 potential to be utilized as an emulsifier in nanoemulsions, as well as in the formation of emulsion g

33 njected dose/ml) as compared to the cationic nanoemulsion (AUClast in plasma - 20.2+/-1.86min*%/injec

34 incorporation of hydrophobic molecules into nanoemulsion based-delivery systems may therefore enable

35 trol could be encapsulated within low-energy nanoemulsion-based delivery systems and protected agains

36 nd therefore has great potential for forming nanoemulsion-based delivery systems for food, personal c

37 des important information for development of nanoemulsion-based delivery systems that increase oral b

38 e useful information for designing effective nanoemulsion-based delivery systems that retard the chem

39 Different O/W nanoemulsion-based delivery systems were developed in or

40 ibility of beta-carotene encapsulated within nanoemulsion-based delivery systems.

41 The purpose of this study was to develop nanoemulsion-based systems to deliver hydrophobic molecu

42 The aim of this work was to fabricate nanoemulsions-based delivery systems to encapsulate resv

43 Two nontoxic, antimicrobial nanoemulsions, BCTP and BCTP 401, have been developed.

44 negligible ( approximately 0%) in orange oil nanoemulsions because no mixed micelles were formed to s

45 be encapsulated in the VE/VE2-PEG2000/water nanoemulsions because of favorable hydrophobic interacti

46 as relatively low ( approximately 2%) in MCT nanoemulsions because the mixed micelles formed were too

47 icelles with elastic cores and corresponding nanoemulsions both manifest high therapeutic efficacy, w

48 thin improved the physical properties of EOC nanoemulsions but did not improve antimicrobial activiti

49 dy was to prepare canola oil based vitamin E nanoemulsions by using food grade mixed surfactants (Twe

50 This study shows that fish oil-in-water nanoemulsions can be formed from sunflower phospholipids

51 The results of this study indicated that nanoemulsions can be used as a delivery system to improv

52 lope glycoprotein formulated with a cationic nanoemulsion (CNE) delivery system was evaluated in rhes

53 after exposure to UV-light: 88% retention in nanoemulsions compared to 50% in dimethylsulphoxide (DMS

54 mesoporous organohydrogels from oil-in-water nanoemulsions containing an end-functionalized oligomeri

55 of C. elegans when they were incubated with nanoemulsions containing conjugated linoleic acid, which

56 Nanoemulsions containing small droplets (d<150 nm) could

57 Stable nanoemulsions containing small droplets (d<70nm) were fo

58 was more effective at promoting oxidation in nanoemulsions containing small droplets because light wa

59 The thermal stability of the nanoemulsions could be improved by adding a cosurfactant

60 Oil-in-water nanoemulsions (d<200nm) were formed using a non-ionic su

61 The antimicrobial activity of the nanoemulsions decreased with increasing ripening inhibit

62 ensis) was formulated as a water-dispersible nanoemulsion (diameter=143nm) using high-intensity ultra

63 All three nanoemulsions did not reveal significant difference from

64 Nanoemulsion droplets were detected at concentrations as

65 much faster for polymeric micelles than for nanoemulsion droplets.

66 different nanoparticle systems, for example, nanoemulsions, drug-loaded block-copolymer micelles, and

67 lex relationship on LCT content for high fat nanoemulsions, due to the opposing effects of lipid dige

68 In this study, three nanoemulsions emulsified by modified starch, Tween 20 an

69 especially evident when either a bioadhesive nanoemulsion (emulsomes) or cholera toxin B subunit (CTB

70 formulation of unique perfluorocarbon (PFC) nanoemulsions enabling intracellular pH measurements in

71 d for polymeric micelles, nanoemulsions, and nanoemulsion-encapsulated drug.

72 All nanoemulsions, except 1wt% protein, showed bimodal dropl

73 oth manifest high therapeutic efficacy, with nanoemulsions exerting lower systemic toxicity than mice

74 The nanoemulsions exhibit an abrupt thermoreversible transit

75 y stable, nontoxic perfluoropolyether (PFPE) nanoemulsions for dual 19F MRI-fluorescence detection.

76 ity, and activity of antimicrobial thyme oil nanoemulsions formed by spontaneous emulsification.

77 tivity of the essential oil in both pure and nanoemulsion forms was measured against an important foo

78 These nanoemulsion formulas are stable, easily dispersed, noni

79 ors treated with either PEG-PDLA micellar or nanoemulsion formulation recurred after the completion o

80 l fraction of micelles with elastic cores in nanoemulsion formulations is desirable for prevention of

81 apeutic properties of polymeric micelles and nanoemulsions generated from micelles.

82 orable hydrophobic interactions; second, the nanoemulsions had a long blood circulation time; finally

83 rfactant-stabilized perfluorocarbon-in-water nanoemulsions has been produced.

84 Nanoemulsions have considerable potential for encapsulat

85 resented of T cells labeled with a dual-mode nanoemulsion in a BALB/c mouse.

86 treal injection of 2-Methoxyestradiol (2-ME) nanoemulsion in regressing neovascularization of a ROP r

87 A 10% dilution of this nanoemulsion in water was used to prepare quinoa-chitosa

88 ults showed that the encapsulation of flavor nanoemulsions in filled hydrogels reduces the release of

89 systems also demonstrated the capability of nanoemulsions in sustained release of resveratrol from d

90 ere thymol was efficiently encapsulated, the nanoemulsions inhibited Botrytis cinerea at 110ppm of th

91 The fluorine nanoemulsion is a clinically applicable cell label capab

92 Intravitreal injection of 2-Methoxyestradiol nanoemulsion is a promising effective method in reductio

93 cs of microbial deactivation showed that the nanoemulsion killed all the bacteria in about 5min, wher

94 (MCT) oil, and WPI were used to make stable nanoemulsions loaded with flavor oil.

95 Prepared nanoemulsions (<200 nm) were readily taken up by both ph

96 It was found that nanoemulsions made with modified starch and whey protein

97 PEG-PDLA stabilized nanoemulsions manifested lower hematological toxicity th

98 The average droplet size for all nanoemulsions measured from the lower diameter peak rang

99 However, nanoemulsion mediated drug delivery may be advantageous,

100 maximum anticancer effect may be achieved by nanoemulsion mediated intravenous delivery.

101 Nasal administration of an oil-in-water nanoemulsion (NE) adjuvant W805EC produces potent system

102 nt that consists of a nontoxic, water-in-oil nanoemulsion (NE).

103 or CpG ODN or a squalene-based oil-in-water nanoemulsion (NE)], upon administration during the secon

104 iH(3)F(8) drastically slowed the ripening of nanoemulsions of the commonly used fluorinated anestheti

105 ithin mixture resulted in stable translucent nanoemulsions of thymol and eugenol with spherical dropl

106 sed on the formulation of oil-in-water (O/W) nanoemulsions of WBO in order to improve the bioaccessib

107 arts, suggesting no apparent toxicity of the nanoemulsions on the small intestine.

108 ering peak intensities were reduced with the nanoemulsion particles.

109 peptide (alpha2AP)-targeted perfluorocarbon nanoemulsions (PFCs) as contrast agent, which is cross-l

110 size and lutein encapsulation efficiency of nanoemulsions prepared by emulsification and solvent eva

111 the particle size and stability of vitamin D nanoemulsions prepared by spontaneous emulsification (SE

112 vitamin D3 encapsulated within oil-in-water nanoemulsions prepared using a natural surfactant (quill

113 Nanoemulsions prepared using long chain triglycerides (c

114 (EOCs) in aqueous systems, properties of EOC nanoemulsions prepared with a LAE and lecithin mixture w

115 nance imaging (MRI) employ intracellular PFC nanoemulsion probes to track cells using (19)F MRI.

116 ing the same polymer, nanoparticle size, and nanoemulsion process.

117 Therefore, nanoemulsions provide an effective and stable system for

118 Nanoemulsions represent one of the emerging formulations

119 inkable gelators enables the freezing of the nanoemulsion's microstructure into a soft hydrogel nanoc

120 nanoemulsion and the CREKA-peptide-modified nanoemulsion showed a higher relative targeting efficien

121 The optimal nanoemulsion showed good stability over time and antioxi

122 Celecoxib loaded nanoemulsions showed a dose dependent uptake in mouse ma

123 orage at 23 degrees C; whereas MS stabilized nanoemulsions showed significant increases in MDD and tu

124 In 2% reduced fat milk, nanoemulsions showed similar antilisterial activities co

125 he potential of utilising oil-in-water (O/W) nanoemulsions stabilised by a globular protein (beta-lac

126 understanding the PFC cell loading dynamics, nanoemulsion stability and cell viability over time.

127 he experimental values for particle size and nanoemulsion stability were 156.13+/-2.3nm and 0.328+/-0

128 -Carotene was incorporated into oil-in-water nanoemulsions stabilized by either a globular protein (b

129 Micelles and nanoemulsions stabilized with PEG-PDLA copolymer manifes

130 ar (oil in water) and reverse (water in oil) nanoemulsions stabilized with the surfactant dioctyl sod

131 adation of beta-carotene encapsulated within nanoemulsions suitable for oral ingestion.

132 urfactant assembly at these relatively large nanoemulsion surfaces and allow for an important compari

133 ng 17-betaE using the CREKA-peptide-modified nanoemulsion system (AUClast in plasma - 263.89+/-21.81m

134 e-Alanine) omega-3-fatty acid oil containing nanoemulsion system in vivo in the wild type C57BL/6 mic

135 the study shows that CREKA-peptide-modified nanoemulsion system was the most suitable vehicle for sy

136 was observed with the CREKA-peptide-modified nanoemulsion system, the study shows that CREKA-peptide-

137 he particles are prepared by an oil-in-water nanoemulsion technique without the need of additional de

138 ably slower in beta-lactoglobulin-stabilised nanoemulsions than in Tween 20-stabilised ones.

139 to direct, mass production of robust double nanoemulsions that are amenable to nanostructured encaps

140 ymer delivery system to encapsulate flavored nanoemulsions that are released under artificial saliva

141 Here we report multifunctional celecoxib nanoemulsions that can be imaged by both near-infrared f

142 In rat 9L glioma cells loaded with nanoemulsion, the local pH of nanoemulsions was longitud

143 The effect of nanoemulsion-thymol-quinoa protein/chitosan coating on m

144 of 5.5 over 3 h, indicating rapid uptake of nanoemulsion to acidic compartments.

145 njections of PTX-loaded PEG-PDLA micelles or nanoemulsions to pancreatic tumor bearing mice resulted

146 Nanoemulsions, unlike microemulsions, have seen little w

147 e was observed in activated macrophages upon nanoemulsion uptake.

148 namics in concentrated silicone oil-in-water nanoemulsions using light scattering.

149 mpared to fabricate and stabilize orange oil nanoemulsions using microfluidization.

150 ctant free, olive-oil based alpha tocopherol nanoemulsions, using a food grade non-ionic surfactant.

151 and bioaccessibility of beta-carotene-loaded nanoemulsions, using a simulated digestion process.

152 A blank nanoemulsion was injected in the right eyes of seven rat

153 The optimal nanoemulsion was obtained when 1% of WBO and 7.3% of a s

154 chemical stability of beta-carotene enriched nanoemulsions was investigated.

155 ls loaded with nanoemulsion, the local pH of nanoemulsions was longitudinally quantified using optica

156 The physical stability of the nanoemulsions was mainly attributed to electrostatic rep

157 The biodegradation of PEG-PDLA stabilized nanoemulsions was monitored by the ultrasonography of na

158 ns on the initial particle size of vitamin D nanoemulsions was studied.

159 independent variables for the preparation of nanoemulsions were 3min.

160 he spectral and pH-sensing properties of the nanoemulsions were characterized in vitro and showed the

161 (<-5 mV) at pH 3.6 indicating MS stabilized nanoemulsions were destabilized by coalescence due to in

162 The nanoemulsions were encapsulated into hydrogels with a me

163 Stable flowable nanoemulsions were formed at 1-2wt% protein concentratio

164 Nanoemulsions were formed using spontaneous emulsificati

165 morphologies of fractionated milk lipids in nanoemulsions were investigated at 4 degrees C.

166 od, on the droplet size and stability of the nanoemulsions were investigated.

167 Thymol nanoemulsions were produced by spontaneous emulsificatio

168 incorporated in the oil phase, QS stabilized nanoemulsions were stable during 2 weeks of storage at 2

169 All nanoemulsions were then evaluated based on permeability

170 Nanoemulsions were then stored at neutral pH and their p

171 However, WPI-stabilized nanoemulsions were unstable to flocculation near the pro

172 t to the treatment with PEG-PLLA micelles or nanoemulsions where all resolved tumors quickly recurred

173 tants for stability; the formation of double nanoemulsions, where both inner and outer droplets are u

174 t efficient formulations were lecithin-based nanoemulsions which were able to transport resveratrol t

175 ed considerably when it was converted into a nanoemulsion, which was attributed to easier access of t

176 ol was encapsulated in the inner core of the nanoemulsions, which provides protection against chemica

177 within the lipid phase increased for low fat nanoemulsions, which was attributed to the increased sol

178 QS was found superior to MS in fabricating nanoemulsion with smallest MDD of 69 nm and turbidity of

179 Nanoemulsions with 3 and 5wt% protein formed strong non-

180 Optical microscopy showed that oil-in-water nanoemulsions with a range of particle diameters (40-500

181 Nanoemulsions with droplet diameters between 160 and 310

182 lipid phase increased, particularly for the nanoemulsions with higher fat contents.

183 ibe the formulation of perfluorocarbon-based nanoemulsions with improved sensitivity for cellular MRI

184 These results will help in design of nanoemulsions with optimum independent variables.

185 Iron(III) tris-beta-diketonate ('FETRIS') nanoemulsions with PFPE have low cytotoxicity (<20%) and

186 Nanoemulsions with small droplet diameters (d<200 nm) co

187 optimise the conditions for preparing stable nanoemulsions with the minimum droplet size.